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Acute pancreatitis is an inﬂammatory process of the pancreatic gland that eventually may lead to a
severe systemic inﬂammatory response. A key event in pancreatic damage is the intracellular activation
of NF-κB and zymogens, involving also calcium, cathepsins, pH disorders, autophagy, and cell death,
particularly necrosis. This review focuses on the new role of redox signaling in acute pancreatitis.
Oxidative stress and redox status are involved in the onset of acute pancreatitis and also in the devel-
opment of the systemic inﬂammatory response, being glutathione depletion, xanthine oxidase activation,
and thiol oxidation in proteins critical features of the disease in the pancreas. On the other hand, the
release of extracellular hemoglobin into the circulation from the ascitic ﬂuid in severe necrotizing
pancreatitis enhances lipid peroxidation in plasma and the inﬂammatory inﬁltrate into the lung and up-
regulates the HIF–VEGF pathway, contributing to the systemic inﬂammatory response. Therefore, redox
signaling and oxidative stress contribute to the local and systemic inﬂammatory response during acute
pancreatitis.
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Acute pancreatitis (AP) is a localized inﬂammation of the
pancreatic gland that often leads to local and systemic complica-
tions, such as lung injury and renal failure. The mortality rate in
patients with AP is approximately 5%, but this percentage rises to
17–20% in patients with necrotizing pancreatitis. Mortality in AP is
ascribed to multiple organ failure that may be triggered by the
associated systemic inﬂammatory response [1]. AP should be
considered, together with sepsis, trauma, burns, and surgery, as a
pathologic condition that may eventually lead to the systemic in-
ﬂammatory response syndrome together with multiple organ
failure [2].
Although the etiology of disease is diverse, alcohol abuse and
duct obstruction by gallstones are the major causes of AP [3].
Obesity is a prognostic factor for severity in the course of AP, as
local and systemic complications are more frequent in obese than
in non-obese patients [3,4]. AP is characterized by interstitial
edema, cell vacuole accumulation and inﬂammatory inﬁltrate of
macrophages and neutrophils together with necrosis of the pan-
creatic tissue [1]. Infection and pancreatic necrosis seem to de-
termine severity and complications in AP [5,6]. Most patients ex-
hibit mild interstitial edematous pancreatitis, which is self-limit-
ing and responds rapidly to conservative management. However,
around 20% of patients suffer severe acute pancreatitis (SAP),
which can progress to a signiﬁcant mortality [7]. Pulmonary, renal,
cardiovascular, central nervous system, and coagulation are most
commonly affected in acute pancreatitis [8].
Clinically, SAP occurs in two stages. In the ﬁrst phase, a sys-
temic inﬂammatory response syndrome might arise leading to
multiple organ failure within the ﬁrst few days [8,9]. If this process
is not restrained or stopped, the second phase will appear, de-
veloping local complications and a subsequent compensatory anti-
inﬂammatory response syndrome (CARS). The function of the
immune system is diminished or impaired during CARS, which
facilitates nosocomial infections, including infected pancreatic
necrosis, one of the most feared complications of the disease [10].
The initiation and development of these stages of SAP is mediated
by diverse pathophysiological mechanisms involved in the sys-
temic inﬂammatory response. This review focuses on the me-
chanisms related to oxidative stress and redox signaling involved
in the initiation and progression of the disease.Early events in acute pancreatitis
The mechanisms involved in the pathogenesis of AP and its
associated pancreatic injury are not completely elucidated, but
they are believed to begin in the acinar cell [11]. Since excessive
alcohol consumption and gallstones are the main causes of acutepancreatitis, both etiological factors play pivotal roles in triggering
acute pancreatitis [3].
Alcohol's toxicity is mediated mainly by its oxidative and non-
oxidative metabolism. Alcohol metabolism leads to an increase in
fatty acid ethyl ester (FAEE) levels through its non-oxidative me-
tabolism, and to the accumulation of acetaldehyde, acetate, and
NADH through its oxidative metabolism [12]. FAEEs exert several
deleterious effects, such as disruption of calcium homeostasis in
acinar cells [13], pathologic zymogen activation [14], and activa-
tion of transcription factors (NF-κB and AP-1) [15]. The latter effect
is enhanced by acetaldehyde leading to increased production of
pro-inﬂammatory cytokines. In addition, alcohol modiﬁes the in-
tracellular redox state of the cell by diminishing the [NAD]/[NADH]
ratio and increasing the [lactate]/[pyruvate] ratio, leading to me-
tabolic alterations and acinar injury [16].
Duct obstruction by gallstones is associated with an increase in
duct pressure and acinar cell exposure to bile acids. This ob-
struction may block acinar exocytosis leading to co-localization of
zymogen and lysosomal granules and early activation of pancreatic
enzymes [17]. Thus, the intrapancreatic activation of trypsinogen
and other zymogen enzymes; inhibition of secretion; alterations in
calcium homeostasis; and activation of cell death pathways are
early events in AP [1,18] leading to inﬂammation of the pancreatic
tissue. In those early events of AP, oxidative stress plays a pivotal
role since reactive oxygen species (ROS) cause direct oxidative
damage to lipids and proteins and modulate redox sensitive
transcription factors and redox-sensitive signal transduction
pathways [19].
Early events in acute pancreatitis will lead to the activation of
several pathophysiological mechanisms that could produce local
and systemic complications and organ failure, which is responsible
for the initial mortality of the disease [8,9]. The main mechanisms
responsible for this systemic progression are pro-inﬂammatory
cytokines, chemokines, ROS, Ca2þ , platelet activating factor, and
adenosine, as well as neuronal and vascular responses [1,20–22].
Furthermore, acinar cells can behave as inﬂammatory cells syn-
thesizing and releasing cytokines, chemokines and adhesion mo-
lecules [9,23,24]. Hence, acinar cells act jointly with leukocytes
triggering the inﬂammatory response after the local damage of the
pancreas.
Zymogen activation
The premature intracellular zymogen activation is one of the
earliest events of AP. The physiological conversion of inactive
trypsinogen to trypsin is catalyzed by the intestinal enzyme en-
terokinase in the gut. Trypsinogen is the most important zymogen
in the initiation of pancreatic injury [25,26]. A recent study de-
monstrates that expression of trypsin in acinar cells is enough to
induce cell death and inﬂammation in pancreatic tissue, using a
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modiﬁcation [27]. Several mechanisms are involved in zymogen
activation such as calcium inﬂux, co-localization of lysosomes, pH
modiﬁcations and autophagy.
Role of Ca2þ
Hypercalcemia is a risk factor for pancreatitis, consequently the
role of cytosolic Ca2þ has been described as a key modulator of the
initiation and development of AP. The continuous increase of cy-
tosolic Ca2þ in acinar cells [28] and the blockade of calcium inﬂux
lead to increase of trypsinogen activation [29].
In this context, the study of the primary sources of Ca2þ is
crucial in the development of the disease. Orabi et al. [30] ex-
amined the role of endoplasmic reticulum membrane ryanodine
receptors (RyR) using a pharmacologic antagonist, dantrolene. This
study suggests that RyR plays an important role in mediating early
acinar cell events during in vivo pancreatitis and contributes to the
severity of the disease. Inhibition of transient receptor potential
channel 3 (TRPC3), a channel involved in the membrane Ca2þ
inﬂux, caused reduced receptor-stimulated Ca2þ inﬂux and a
lower sustained Ca2þ increase, demonstrating that TRPC3 deﬁ-
ciency prevents the intra-acinar zymogen activation and pan-
creatitis severity in vivo [31]. Moreover, ethanol and bile acid
metabolites cause a sustained pathologic Ca2þ increase due to ATP
depletion [32].
Another relevant focus is the downstream target of Ca2þ , such
as calcineurin, which is an Ca2þ-activated protein phosphatase.
Mice pretreated with tacrolimus, a calcineurin inhibitor, showed
reduced protease activation and decreased severity of the pan-
creatitis episode after cerulein hyperstimulation [33].
Colocalization of lysosomes
During decades, the major hypothesis to explain zymogen ac-
tivation within acinar cells has been the co-localization of lyso-
somes with pancreatic digestive enzymes [34,35]. This hypothesis
suggests that during the early stages of AP, pancreatic-derived
digestive zymogens become co-localized with lysosomal hydro-
lases in cytoplasmic vacuoles in acinar cell resulting in trypsinogen
activation produced by lysosomal hydrolases, such as cathepsin B
[36].
Nevertheless, subcellular redistribution of cathepsin B induces
neither spontaneous trypsinogen activation nor pancreatitis [37].
This ﬁnding suggests that co-localization needs another condition,
most likely low pH. In vitro studies showed that a low pH increases
the catalytic capacity of cathepsin B [35]. Thus, stimulation of
vacuolar ATPase activity appears to be required for zymogen ac-
tivation in the acinar cell [38].
pH effects
Low extracellular pH (pHe) promotes the development of
pancreatitis. Reducing pHe from 7.4 to 7.0 sensitizes acinar cells to
pancreatitis-like responses both in vitro and in vivo in a cerulein
model of pancreatitis [39].
The injurious effects of low pHe on the acinar cell are likely
mediated through changes in Ca2þ signaling. RyR inhibitors sig-
niﬁcantly reduce the sensitizing effects of low pHe on zymogen
activation and cellular injury. This ﬁnding suggests that enhanced
RyR-mediated Ca2þ signaling in the basolateral region of the aci-
nar cell is responsible for the effects of low pHe in the exocrine
pancreas [40].
In addition, Behrendorff et al. [41] demonstrated that exocy-
tosis of zymogen granules from acinar cells leads to luminal
acidiﬁcation, and this process could contribute to tissue injury in
cases of AP.Autophagy in acute pancreatitis
The autophagic response is a complex process involving lyso-
somal-dependent recycling of intracellular components. Autop-
hagy occurs at a basal rate in most cells, where it acts as a quality
control mechanism to eliminate protein aggregates and damaged
or unneeded organelles. Basal autophagy rate is higher in mouse
exocrine pancreas than in liver, kidney, heart, or endocrine pan-
creas [42], since the exocrine pancreas is characterized by a high
rate of protein synthesis.
Another interesting feature of AP is the accumulation of au-
tophagic vacuoles in the acinar cell [43], but the role of autophagy
in AP is still under debate. On the one hand, autophagy exerts
damage effects in acinar cells during the onset of AP by activating
trypsinogen to trypsin through delivering trypsinogen to the ly-
sosome [44]. On the other hand, Marerinova et al. [45] showed
that retarded autophagy is associated with an imbalance between
cathepsin L, which degrades trypsinogen and trypsin, and cathe-
psin B, which converts trypsinogen into trypsin, resulting in intra-
acinar accumulation of active trypsin in pancreatitis. Thus, a de-
ﬁcient lysosomal degradation may be a dominant mechanism for
increased intra-acinar trypsin in pancreatitis.
Recently, another group described autophagy as a selective
process, called zymophagy, that modulates pancreatitis-induced
intracellular zymogen activation. This process seems to prevent
cell death in early pancreatitis [46].
Inﬂammatory response in acute pancreatitis
Role of NF-κB
It has been described that activation of NF-κB occurs early in AP
simultaneously with intracellular trypsinogen activation [27]. By
contrast, expression of active trypsin in vitro failed to activate NF-
κB, suggesting that these two events are independents [47].
NF-κB is a transcription factor that plays a pivotal role in reg-
ulating the inﬂammatory response in mammals [48]. The NF-κB
family includes ﬁve members: p50, p52, RelA/p65, c-Rel, and RelB
[48]. NF-κB develops a crucial role in the pathogenesis of AP [49].
It is activated early in AP, not only in leukocytes but also within
pancreatic acinar cells [50]. Adenoviral-mediated overexpression
of the active RelA/p65 NF-κB subunit induced severe pancreatitis
in mice, characterized by NF-κB activation, up-regulation of NF-κB
target genes, neutrophil inﬁltration, and widespread damage to
pancreatic acinar cells [51]. Furthermore, constitutive over-
expression of active IKK2 – a key mediator of the canonical NF-κB
pathway – in pancreatic acinar cells was sufﬁcient to induce AP
[49]. Indeed, it caused edema, necrosis, leukocyte inﬁltration, as
well as increased serum lipase activity and up-regulation of NF-κB
target genes in the pancreas [49]. Histological damage and TNF-α
expression were reduced in cerulein-induced pancreatitis in mice
deﬁcient in NF-κB [52].
Role of inﬂammatory cytokines in acute pancreatitis
Since cytokines exhibit a cross-talk with oxidative stress and
are key players in the systemic response in acute pancreatitis [53],
we have also reviewed their role. Cytokines are low molecular
weight soluble proteins produced during stress or injury in nu-
merous cell types as means of cell-to-cell communication [54,55].
Activated leukocytes are the main source of cytokines, which are
consequently essential components of the inﬂammatory cascade.
The primary members of the cytokine inﬂammatory family, par-
ticularly interleukin 1β (IL-1β) and tumor necrosis factor alpha
(TNF-α), induce their own expression as well as other cytokines
expression by positive feedback mechanisms that lead to ampli-
ﬁcation of the inﬂammatory response and are critically involved in
the systemic inﬂammatory response syndrome [55,56]. Since
dexamethasone treatment does not affect trypsinogen activation,
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mediately after this zymogen activation [57].
Leukocyte recruitment within the inﬂamed pancreas begins as
early as 3 hours after AP induction with rolling and adhesion of the
circulating leukocytes to the endothelium [58]. Activated macro-
phages release pro-inﬂammatory cytokines, such as IL-1β, IL-6 and
TNF-α, in response to the local damage of the pancreas [9]. As
indicated above, local cells contribute to increase serum levels of
IL-1β, IL-6 and TNF-α in experimental AP [23]. These levels cor-
relate with the degree of pancreatic inﬂammation [59–61]. Thus,
peripheral blood monocyte and neutrophil counts correlate with
plasma inﬂammatory cytokines and TNF-α soluble receptors in AP
[62].
TNF-α and interleukin-1β (IL-1β) are considered primary cyto-
kines initiating and propagating most of the consequences of the
systemic inﬂammatory response in AP [21,22]. They amplify the
inﬂammatory cascade by activating mitogen-activated protein ki-
nases (MAPKs) and nuclear factor-κB (NF-κB), which induce the
release of chemokines and other cytokines, and a positive feedback
loop, which up-regulates their own expression [63]. Accordingly,
the systemic inﬂammatory response in severe necrotizing AP was
restrained by inhibiting tissue injury, pro-inﬂammatory cytokine
production, acinar cell death, and cytokine production via inhibi-
tion of NF-κB and ERK1/2 activation [64].
TNF-α is released from different tissues in the course of AP.
There is an induction of its mRNA and protein in pancreas [65].
Although acinar cells may produce TNF-α, leukocytes from the
inﬂammatory inﬁltrate within the pancreatic tissue are considered
as the predominant source [55]. Fig. 1 shows the presence of TNF-α
in rat pancreatic tissue after induction of acute pancreatitis with
3.5% of sodium taurocholate (3 h). Necrotic tissue and in-
ﬂammatory inﬁltrate are associated with the presence of TNF-α
[66].
TNF-α triggers cell death through divergent mechanisms
mediated by protein kinase C and causes NF-κB activation leading
to pro-inﬂammatory up-regulation [67]. We found that inhibition
of TNF-α production by pentoxifylline markedly diminished leu-
kocyte inﬁltrate, edema and glutathione depletion in pancreas as
well as reduced serum lipase activity after cerulein-induced pan-
creatitis in rats [68].
The production of IL-1β in AP may be also pancreatic and ex-
trapancreatic. Similarly to TNF-α, few hours after pancreatic IL-1β
levels increase, both its mRNA and protein are induced in lungs
and liver [65]. Leukocytes from the inﬂammatory inﬁltrate within
the pancreatic tissue appear to be the predominant source of IL-1β
[55]. IL-1 production is closely associated with induction of other
genes within the same gene-family, such as that encoding for in-
terleukin 1β-converting enzyme (ICE), which is necessary for
cleavage of pro-IL-1 protein into its active form [55].Fig. 1. Immunohistochemical detection of TNF-α production by acinar cells iIL-1 exhibits similar actions to TNF-α. Thus, it induces the re-
lease of other cytokines, such as IL-2 by T-helper lymphocytes and
cellular adhesion molecules, which extend the inﬂammatory re-
sponse [9]. IL-1β seems to be a pivotal inﬂammatory mediator in
cell death associated with sterile inﬂammation [69], which is an
important event in AP.
Finally, the inﬂammatory response in AP is modulated by a
balance between pro-inﬂammatory and anti-inﬂammatory med-
iators. IL-6 and IL-8 are markers of severity in AP. IL-6 mediates the
acute-phase response, whereas IL-8 participates in neutrophil
chemotaxis, activation, and degranulation [70]. Nevertheless, the
elevation of IL-6 levels should not be considered necessarily pa-
thogenic, because it also induces the expression of suppressor of
cytokine signals as a compensatory response mediated by STAT3
that limits the extent of inﬂammation [71]. IL-10 and pancreatitis-
associated protein-1 (PAP-1) are major anti-inﬂammatory media-
tors in AP. IL-10 diminishes pancreatic damage [72] and exhibits
anti-inﬂammatory actions mainly through inhibition of IL-1β and
TNF-α [73]. Pap-1 knockout mice exhibited enhanced pancreatic
inﬂammation in mild cerulein-induced pancreatitis [74]. PAP-1
reduced the inﬂammatory response by blocking NF-κB activation
and decreasing the expression of pro-inﬂammatory cytokines and
adhesion molecules [75,76].Role of DAMPs and inﬂammasome in acute pancreatitis
Cell necrosis releases damage associated molecular patterns
(DAMPs) to the extracellular space, which stimulate the in-
ﬂammatory response through DAMP-receptors, mainly TOLL and
purinergic receptors [77]. DAMPs contribute to the pathogenesis of
acute pancreatitis as blockade of the DAMP HMBG1 reduces the
inﬂammatory response and cell necrosis in severe acute pancrea-
titis [78].
DAMPs trigger activation of the large cytoplasmic multiprotein
complex inﬂammasome that leads to pro-IL1β cleavage and IL-1β
secretion [79]. Caspase-1, ASC, and NLRP3 are central components
of the inﬂammasome. Hoque et al. have demonstrated that the
inﬂammasome is markedly activated during pancreatitis through
DAMP-receptors TLR9 and P2X7 [80]. Furthermore, caspase 1,
NLRP3 and ASC are required for NF-κB activation and maximal
pancreatitis. Accordingly, antagonists of TLR9 and P2X7 reduced
markedly the inﬂammatory response in acute pancreatitis [80].
Interestingly, mitochondrial ROS act as signal-transducing
molecules that up-regulate pro-inﬂammatory cytokine production
via inﬂammasome-dependent pathways [81–83]. Hence, further
studies are needed to clarify the role of mitochondrial reactive
oxygen species (ROS) in the inﬂammatory response in pancreatitis.n rat pancreas 3 h after AP induction with 3.5% of sodium taurocholate.
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During last decades numerous studies have highlighted the role
of oxidative stress in the acute inﬂammatory response, particularly
in the pancreatic injury associated with AP [84–86]. In the eighties,
Sanfey and co-workers reported the beneﬁcial effects of pre-
treatments with antioxidants, such as superoxide dismutase (SOD)
and catalase (CAT), providing an indirect proof for the involvement
of oxidative stress in AP [87]. They also emphasized the role of the
pro-oxidant enzyme xanthine oxidase (XO) in AP. Accordingly they
suggested that allopurinol, an inhibitor of XO, could be a potential
therapy for the disease [87].
Later several groups including ours studied in depth oxidative
stress, XO, and other pro-oxidants and antioxidant agents in AP
[88,89]. As a result, oxidative stress is presently considered as a
key mediator not only of the early local events associated with AP,
but also of the associated systemic inﬂammatory response syn-
drome [89].
The in situ demonstration of oxygen free radical formation
during pancreatitis in rats and humans was performed by Telek
and co-workers using cerium capture of oxygen free radicals
[90,91]. The source of ROS may differ depending on the experi-
mental model of AP. In mild AP caused by overstimulation with
cerulein, free radical generation would be mainly associated with
inﬁltration of activated neutrophils, whereas in necrotic AP in-
duced by taurocholate retrograde perfusion it seems to be mainly
due to the conversion of XO dehydrogenase (XDH) to XO [92].
Other pro-oxidant enzymes that contribute to pancreatic in-
ﬂammation are cytochrome P450 [93,94] and specially NADPH
oxidase [95].
Experimental AP is characterized by marked depletion of re-
duced glutathione in pancreas together with increased lipid per-
oxidation in the tissue and in plasma [96]. Therefore, oxidative
stress is present in both local and systemic responses during the
disease.
Moreover, clinical studies have also veriﬁed the presence of
oxidative stress during AP [97]. Indeed, lipid peroxidation, mye-
loperoxidase activity, and protein carbonyls increase in plasma of
patients with SAP [98–100]. All these parameters are generally
related to severity of the disease both in clinical and experimental
studies. Thus, the increase in malondialdehyde (MDA) levels cor-
relates with tissue injury in AP [100,101]. Furthermore, superoxide
radical and lipid peroxide levels also increase in blood of patients
and animals with AP, and these changes correlate with the degree
of AP severity [85,102]. Increased levels of MDA have also been
associated with pancreatitis-associated multiple organ dysfunc-
tion [103]. Furthermore, oxidative stress markers correlate with
serum phospholipase A2 and plasma polymorphonuclear elastase
activities, two prognostic parameters in AP [104]. In addition,
concentrations of antioxidant vitamins are diminished in AP and
are inversely related to the rise in C reactive protein level in this
disease [105].
Reactive nitrogen species (RNS) are also involved in the pa-
thophysiology of AP [106]. In inﬂammatory processes such as AP,
inducible nitric oxide synthase (iNOS) contributes to large nitric
oxide (NO) formation [107,108]. It has been suggested that a lim-
ited normal amount of NO production has beneﬁcial effects in
experimental edematous AP but uncontrolled over-production of
NO may be detrimental, which suggests differing roles for each
NOS isoform [109,110]. Endothelial nitric oxide synthase (eNOS)
reduces the severity of the initial phase of experimental AP [111].
Thus, endogenous NO protects against oxidative damage since the
inhibition of NOS by N-nitro-L-arginine methyl ester increases li-
pid peroxidation and protein oxidation in some subcellular frac-
tions [112]. However in mice deﬁcient in iNOS with AP, lipid per-
oxidation, the expression of adhesion molecules, and tissuedamage were markedly restrained [113].
NO production and NOS expression seem to be differentially
regulated temporally and in magnitude in the pancreas and lungs
in response to cerulein hyper-stimulation [111]. AP provoked a
deleterious effect on endothelium-dependent relaxing response
for acetylcholine (Ach) in vitro and other hemodynamic dis-
turbances, which were associated with high plasma NO levels as
consequence of intense inﬂammatory response [114].
Xanthine oxidase and acute pancreatitis
Due to a signiﬁcant potential capacity to generate large
amounts of free radicals when activated from xanthine dehy-
drogenase (XDH), this enzyme has been studied in depth in
ischemia–reperfusion processes and in many other diseases. In AP,
the enzyme exhibits a major role in local and systemic processes.
Two different mechanisms may account for the activation and
conversion of XDH to xanthine oxidase (XO) in AP. On the one
hand, it has been described that activation of chymotrypsinogen to
chymotrypsin may lead to activation of XDH to XO [115], which is a
typical cellular process of the disease. On the other hand, oxidation
of thiol groups could also lead to XO formation [116].
XO inhibition with allopurinol or derivatives has been asso-
ciated with beneﬁcial pancreatic effects in AP [117,118]. Edema,
necrosis and pancreatic inﬂammation were reduced by adminis-
tration of XO inhibitors.
Systemic effects of XO have also been described. Closa et al.
suggested that the hydrolytic activity of α-amylase that markedly
increases in AP cleaves the binding of XDH to glycoproteins of
endothelial cells releasing large amounts of the enzyme to sys-
temic circulation [119,120]. Activation to XO may also be produced
by proteolytic enzymes present in plasma [119,120]. Finally, lungs
provide oxygen to the enzyme which is needed for free radical
generation [121]. Consequently, pulmonary oxidative damage is
produced by XO [121], and administration of oxypurinol, a water-
soluble derivative of allopurinol, prevents pulmonary damage as it
abrogates the increase in myeloperoxidase activity and leukocyte
inﬁltration in experimental AP [122].
However clinical effects of allopurinol in preventing post-ERCP
pancreatitis and in the management of chronic and AP are not
clear and further well-designed large clinical studies need to be
conducted in this regard [123,124]. Further review of antioxidant
therapies is discussed below.
Glutathione and acute pancreatitis
Reduced glutathione (GSH) is the major non-protein thiol in
mammalian cells and plays a central role as antioxidant. It is in
equilibrium with oxidized glutathione (GSSG) and the ratio be-
tween GSSG and GSH is a reliable indicator of oxidative stress
because it reﬂects the balance between antioxidant status and pro-
oxidant reactions in cells [125,126]. Thus, the glutathione redox
status – characterized by high abundance of the reduced form –
maintains the intracellular thiol/disulﬁde redox status. GSH con-
centration in the pancreas is one of the largest in the body and this
tissue exhibits active transsulfuration pathway and GSH synthesis
despite the relatively low activity of glutamate cysteine ligase
(GCL) [106].
GSH depletion in the pancreatic tissue is a hallmark during the
initial phase of AP [127,128]. Pre-treatments with glutathione
monoethyl ester exhibited beneﬁcial effects in AP by increasing
pancreatic GSH levels [128], whereas inhibition of GSH synthesis
with L-buthionine-(S,R)-sulfoximine (BSO) led to more pancreatic
necrosis and reduced survival in rats with AP [129]. Furthermore,
an association between certain genetic polymorphisms of glu-
tathione S-transferase and severe AP has been reported [130].
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from mild to severe AP [131].
The biological reason for early GSH depletion in AP is not well-
established. It was suggested that GSH depletion could allow a
premature activation of digestive enzymes inside acinar cells
triggering the inﬂammatory process [132]. However, glutathione
depletion itself does not produce AP [133,134].
Our group found early glutathione depletion but not glu-
tathione oxidation in pancreas in the early stage of experimental
AP [68,135]. Therefore, ROS detoxiﬁcation associated with the in-
ﬂammatory process does not appear to be the major cause for the
early glutathione depletion. Alternatively, Meister suggested that
depletion of pancreatic glutathione may be due, at least in part, to
the activation of pro-enzymes, since activated proteases such as
carboxypeptidase may cleave GSH [136]. In fact, trypsinogen ac-
tivation is accompanied by glutathione depletion in experimental
AP [137].
In addition, we also showed that early up-regulation of GCL
expression in pancreas occurs only in experimental mild edema-
tous AP but not in severe necrotic AP [131]. Accordingly, rapid
recovery of GSH levels occurs only in mild AP, while in the necrotic
model the failure in up-regulation of GCL avoids the rapid increase
in GSH levels. The marked increase in cytosolic pancreatic ribo-
nuclease that occurs only during severe necrotic pancreatitis
might be responsible for GCL mRNA degradation speciﬁcally in the
severe form of the disease [131].
Pancreatic glutathione levels may be also associated with the
increased severity of AP in obesity since pancreatic basal GSH le-
vels and GSH levels after AP are decreased in obese animals in
comparison with lean animals [138].
Extracellular hemoglobin and acute pancreatitis
Recently our group has demonstrated that severe acute pan-
creatitis is associated with marked increase in extracellular he-
moglobin in plasma that comes from the ascitic ﬂuid [139]. On the
one hand, extracellular hemoglobin enhances lipid peroxidation,
up-regulates pro-inﬂammatory cytokines Il-1β and TNF-α, and
lowers anti-inﬂammatory IL-10 levels in abdominal adipose tissue.
On the other hand, extracellular hemoglobin stimulates the leu-
kocytic inﬁltrate in the lung and induces the hypoxia inducible
factor (HIF)–vascular endothelial growth factor (VEGF) pathway
[139]. Since VEGF increases vascular permeability in the lung and
it may trigger pulmonary edema [140,141], the increase in extra-
cellular hemoglobin might critically contribute to the development
of pulmonary distress syndrome as a major complication of acute
pancreatitis.
In this review we focus not only in the deleterious effects of
free radicals by oxidation of biomolecules in AP, but also in the
modulation of cell signaling and gene expression by redox status
in this disease.Redox signaling and inﬂammatory response in acute
pancreatitis
Recently, new and important roles of oxidative and nitrosative
stress in cell signaling have been described [142,143]. In general,
modulation of intracellular signaling by redox unbalance is pro-
duced by two different mechanisms. On the one hand, oxidative
species such as H2O2 and α and β-unsaturated aldehydes are
considered as second messengers in the inﬂammatory response
[144]. On the other hand, redox status affects cellular signal
transduction through covalent modiﬁcation of redox sensors [145].
Sulfur switches of sensitive targets, which include not only cy-
steine (cys) but also methionine (Met) residues, allow a transientoxidation of proteins to enable transmission of a signal and sub-
sequent enzymatic reduction to their basal oxidation state.
Redox unbalance not only causes oxidative damage but also
acts as intracellular signal in inﬂammatory processes, particularly
up-regulating pro-inﬂammatory genes [106]. Indeed, ROS act as
inﬂammatory mediators through the activation, migration, and
adhesion of leukocytes, as well as by enhancing the expression of
other mediators, such as cytokines, chemokines, and adhesion
molecules [146,147]. In pancreatic acinar cells ROS induce activa-
tion of NF-κB as described above [148]. Furthermore, ROS gener-
ated by XO during AP induce up-regulation of lung P-selectin, an
important mediator of neutrophil inﬁltration [146].
H2O2 is a second messenger of NADPH oxidases, which appear
to be the major source of ROS in inﬂammation [149]. The en-
dosomal production of superoxide by NADPH oxidase promotes
the redox-dependent recruitment of TRAFs to the TNFR1/TRADD
complex and subsequent NF-κB activation [150]. NF-κB may be
activated by H2O2 and other pro-oxidants in many cell types, and
its activation can be inhibited by antioxidants, as mentioned be-
fore [151]. However, the ability of oxidative stress to activate NF-κB
depends on the cell type, the ROS generating system, and the
antioxidant levels [152]. Moreover, H2O2 also modulates activation
of MAPK kinase apoptosis signal-regulating kinase-1 (ASK1), an
upstream kinase that activates the JNK and p38 MAPK pathways
[153,154]. In addition, ROS are involved in NADPH oxidase-de-
pendent signaling platforms associated with caveolae, lipid rafts,
and nucleus [149].
In experimental AP, NADPH oxidase expression and activity are
increased in pancreas [155]. Interestingly, mice deﬁcient in NADPH
oxidase exhibited attenuation of the cerulein-induced trypsin ac-
tivation in the pancreas [156]. Free radical generation through
NADPH oxidase would be related not only to inﬁltration of acti-
vated neutrophils [92], but also to acinar cell apoptosis [157]. In-
deed, NADPH oxidase up-regulates IL-6 and mediates ROS-induced
apoptosis in pancreatic AR42J acinar cells stimulated with the
cholecystokinin analog cerulein [157].
In inﬂammatory processes, other oxidized molecules such as
isoprostanes may trigger signaling through G-protein coupled re-
ceptors [158], whereas 4-hydroxy-2-nonenal causes signaling
through JNK, protein kinase C, Keap1 and protein tyrosine phos-
phatase SHP1 [159–161]. In addition, oxidized phospholipids and
cholesterol esters are “damage-associated molecular patterns”
(DAMPs) that activate “pattern recognition receptors”, such as toll-
like receptor 4 and CD36, triggering an immune response with up-
regulation of pro-inﬂammatory genes as previously mentioned in
[162]. Pancreatic-associated fat necrosis and ascites increased the
concentrations of isoprostanes, lipoperoxides, lipid chlorohydrins,
and free fatty acid which markedly enhance the activation of en-
dothelial cells and inﬂammation [163].
On the other hand, it should be taken into account that al-
though ROS are associated with SIRS, the formation of ROS in
acinar cells might be protective by triggering apoptotic cell death
instead of necrosis [164].
Role of ROS in NF-κB activation in acute pancreatitis
NF-κB activation may be subjected to redox regulation through
upstream protein kinases and phosphatases prone to oxidation or
thiolation [165,166]. Thus, ROS-dependent tyrosine phosphoryla-
tion of IκB may trigger its dissociation from NF-κB dimers and
subsequently NF-κB activation [165]. Accordingly, NF-κB may be
activated by hydrogen peroxide (H2O2) and other pro-oxidants in
many cell types, and its activation can be abrogated by anti-
oxidants [151]. However, as mentioned before the ability of oxi-
dative stress to activate NF-κB depends on the cell type and the
ROS-generating system [106,152,167]. Indeed, NADPH oxidase was
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in monocytes, whereas 5-lipoxygenase was the source of ROS in IL-
1β-stimulated lymphoid cells and it was required for NF-κB acti-
vation in these cells [71]. Furthermore, certain cell types such as
mouse alveolar epithelial cells did not trigger NF-κB activation
upon H2O2 exposure, and even H2O2 may diminish TNF-α-induced
NF-κB nuclear translocation [168]. Reduced NF-κB activation by
H2O2 was mediated by inhibition of IKK activity due to oxidation of
cysteine residues present in the IKK complex [168]. In addition,
NF-κB, particularly p50, is a direct target for oxidation that can
decrease its ability to bind to DNA [169]. Cys-62 of p50 is oxidized
in the cytoplasm and needs to be reduced in the nucleus for the
DNA binding activity of NF-κB [165,169].
ROS seem to promote NF-κB activation in the early course of
pancreatitis [106]. Pretreatment with N-acetylcysteine (NAC) ab-
rogated NF-κB activation in various experimental models of AP
[170–175]. Pancreatic acinar cells respond to oxidants through NF-
κB activation. Thus, H2O2 induced NF-κB activation in vitro in
pancreatic acinar cells [176] and NAC inhibited NF-κB activation in
acinar cells in response to cerulein hyper-stimulation [177].
ROS and calcium signaling
Disruption of Ca2þ signaling in pancreatic acinar cells seems to
play a pivotal role in pathogenesis of AP [28,29,178]. Thus, sti-
mulation of acinar cells with CCK causes a sustained increase in
cytosolic Ca2þ , intracellular digestive enzyme activation, and ne-
crosis [179]. Conversely, blockade of Ca2þ channels reduces the
severity of experimental acute pancreatitis [180].
It is well known that Ca2þ homeostasis is sensitive to cellular
redox status [181], and hence, their interplay affects the onset and
development of acute pancreatitis. IP3R and RyR receptors exhibit
redox-sensitive cysteine residues that may explain the regulatory
role of ROS in Ca2þ channels [45,182]. Importantly, thiol oxidation
in these residues increases the activity of endoplasmic reticulum
Ca2þ channels, and consequently rise cytosolic Ca2þ levels leading
to premature intracellular activation of trypsinogen [183,184].
Recently, a novel mechanism of Ca2þ entry in acinar cells re-
lated to formation of a STIM1-Orai complex has been reported
[185]. It is worth noting that orai1 is a redox-sensitive protein
involved in Ca2þ signaling [186], and thus it may contribute to the
redox regulation of Ca2þ levels in acinar cells.
Another protein involved in the control of Ca2þ homeostasis in
the pancreas is the plasma membrane Ca2þ-ATPase pump. Bruce
et al. reported that high H2O2 concentrations inhibit the pump
activity and diminished the Ca2þ clearance through the plasma
membrane [187]. They also found that this pump failure was due
to mitochondrial depolarization, which produced a decrease in the
ATP production [188].
Cell death by apoptosis or necrosis depends on the duration
and severity of the disturbance of cytosolic calcium levels in
pancreatic acinar cells. For example, a transient elevation of cy-
tosolic Ca2þ levels induced by bile acids increases Ca2þ uptake
into mitochondria, generates mitochondrial ROS, and causes cas-
pase activation and apoptosis [189]. In addition, ROS promotes
cytochrome c release and apoptosis in acinar cells [190]. The ad-
ministration of NAC, ETC inhibitors (rotenone and antimycin-A) or
Ca2þ chelators (BAPTA-AM) decreases mitochondrial ROS pro-
duction and prevents bile acid-induce apoptosis [189,191]. How-
ever, Ca2þ exerted two opposite effects via ROS on cytochrome c
release in acinar cells. Cytochrome c release, caspase activation,
and apoptosis are stimulated by Ca2þ and ROS, but inhibited by
the Ca2þ-induced loss of mitochondrial membrane potential
(ΔΨm) leading in this case to necrosis [190]. Thus, it seems that
pancreatic mitochondria are more sensitive to Ca2þ than other
mitochondria, such as liver ones [190].On the other hand, bile acids, CCK, or non-oxidative ethanol
metabolites may trigger sustained elevations of cytosolic Ca2þ
causing necrosis in acinar cells [179,192]. The massive inﬂux of
Ca2þ into the mitochondrial matrix may be explained by the
opening of the mitochondrial permeability transition pore (MPTP)
channel that is regulated by the intracellular Ca2þ and ROS levels
[193].
Disulﬁde stress in acute pancreatitis
We have recently shown that in acute pancreatitis glutathione
depletion in pancreas is not associated with glutathione oxidation,
but it is rather triggered by glutathione breakdown that yields to a
marked increase in cysteine and gamma-glutamyl cysteine [135].
Furthermore, cysteine is oxidized to cystine and gamma-glutamyl
cysteine to bis-gamma glutamyl cystine promoting protein cy-
steinylation and gamma-glutamyl cysteinylation without sig-
niﬁcant increases in protein glutathionylation [135]. This speciﬁc
oxidation of thiols in proteins upon acute inﬂammation would be a
model of disulﬁde stress that leads to inactivation of protein
phosphatases, such as serine protein phosphatase 2A and tyrosine
phosphatase SHP1, which would favor MAPK activation and am-
pliﬁcation of the inﬂammatory cascade. Other relevant redox-
signaling thiols targets of disulﬁde stress include Keap1, thior-
edoxin 1, disulﬁde isomerase, peroxiredoxin, and endonuclease
APE1/Ref1 [135]. Their oxidation should certainly contribute to
acinar cell damage and death in acute pancreatitis. In addition,
redox buffers such as albumin and ribonuclease inhibitor are also
oxidized in acute pancreatitis and their contribution to cell da-
mage should be further explored.
As mentioned above, oxidative stress and redox status act as a
cell signaling modulator by covalent modiﬁcation of sulfur re-
sidues of proteins within amino acids such as cysteine or me-
thionine. Protein phosphatases are an important example of redox
signaling as their activity is modulated by oxidative stress. They
are key sensors of the cellular redox state since reversible oxida-
tion of thiols (–SH) in protein phosphatases to form intramolecular
disulﬁde bridges (–S–S–) or sulfenyl-amide bonds leads to their
transient inactivation [83,194]. Protein phosphatases are classiﬁed
into two major groups: serine/threonine phosphatases (PPs) – PP1,
PP2A, PP2B (calcineurin) and the metallo-dependent phosphatase
PP2C – and protein tyrosine phosphatases (PTPs) [195]. This latter
group includes membrane protein phosphatases such as CD45,
cytosolic phosphatases such as SHP1 and SHP2, and dual-speciﬁ-
city phosphatases also called MAPK phosphatases (MKPs).
Redox unbalance promotes activation of phosphorylation
pathways such as MAPKs through inactivation of protein phos-
phatases. The activation of MAPKs by ROS seems to be mediated
by inhibition of MKPs via different signaling pathways [196]. MKPs
belong to a large group of protein tyrosine phosphatases, which
are critical molecular targets of ROS since their catalytic cysteine is
much more sensitive to reversible oxidation than other cysteines
due to its low pKa [197,198]. Mild oxidative stress causes reversible
oxidation of the catalytic cysteine to sulfenic acid (–S–OH), while
intense oxidative stress may trigger the irreversible formation of
sulﬁnic (–S–O2H) and sulfonic acids (–S–O3H) [199]. Nevertheless,
members of the PTP superfamily exhibit large variation in their
sensitivity towards oxidation. Some PTPs are highly sensitive to
oxidation – such as PTEN or Sac1 –, whereas others – such as
myotubularin lipid phosphatase – are resistant [200,201].
Serine/threonine phosphatase PP2A activity decreases when
cysteines from the active site of the catalytic subunit PP2Ac form
intramolecular bonds with vicinal thiols or intermolecular dis-
ulﬁde bonds with regulatory subunits [202,203]. Accordingly,
PP2A activity is inhibited by GSSG or H2O2, being this effect pre-
vented by DTT [204]. Calcineurin (PP2B) may also be inactivated by
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decreases both its afﬁnity towards Ca2þ and transactivation of
target genes [207]. Methionine oxidation may diminish calcineurin
activity too [208]. We have shown that disulﬁde stress causes
oxidation of PP2A through formation of intramolecular disulﬁdes
in experimental AP, and moreover the loss of pancreatic PP2A
activity that occurs in AP may be rescued by treatment with
N-acetyl cysteine [135].
Consequently, ROS and particularly those formed by NADPH
oxidases may govern the balance between MAPKs and some
phosphatases controlling the inﬂammatory response by redox
signaling [209]. Activation of these phosphorylation pathways, NF-
κB, and other activators of transcription leads to changes in
chromatin structure with a special role of histone acetylation in
order to trigger the expression of inﬂammatory genes [144].
Histone acetylation and redox signaling in acute pancreatitis
During last decades, it has been reported that CBP/p300 histone
acetyltransferase (HAT) complex regulates the expression of pro-
inﬂammatory cytokines through NF-κB and STAT pathways
[210,211]. Indeed, CBP and p300 HATs are coactivators of RelA/p65
and are required for transcription of numerous targets of NF-κB,
such as IL-6, IL-8, iNOS, E-selectin, and VCAM-1 [212]. Further-
more, transcription factor STAT3, which decisively participates in
the acute-phase inﬂammatory response, is regulated by acetyla-
tion and phosphorylation [213]. Indeed, STAT3 acetylation is trig-
gered by p300 and is critical to form STAT3 dimers that are re-
quired for transcriptional activation of cytokine IL-6 [213].
Redox signaling may occur in inﬂammation through inactiva-
tion of histone deacetylases (HDACs). In fact, glutathione depletion
and ROS generation in macrophages may lower HDACs activity
leading to increased IL-8 expression [214]. Regarding antioxidant
defense, Nrf-2 deﬁciency leads to decreased HDAC2 levels in the
lung and hence to enhanced inﬂammatory response [215].
In acute pancreatitis, modulation of NF-κB, ERK, and histone
acetylation in inﬂammatory processes may be regulated by redox-
sensitive serine/threonine protein phosphatase PP2A. We found that
PP2A activity markedly decreases during acute pancreatitis as well as
serine/threonine protein phosphatase PP2B and PP2C activities [216].
Administration of pentoxifylline, a phosphodiesterase inhibitor,
prevented the loss of PP2A activity without affecting the other ser-
ine/threonine protein phosphatases, and abrogated the recruitment
of HATs CBP and P/CAF to the promoters of pro-inﬂammatory genes,
such as TNF-α and iNOS [216]. In addition to this effect on HATs, it
also reduced the recruitment of transcriptions factors regulated by
phosphorylation, such as NF-κB and C/EBPβ [216].
We also studied the epigenetic regulation of pro-inﬂammatory
genes by kinetic analysis of the recruitment of transcriptions fac-
tors to their promoters [66]. Our results showed that up-regulation
of early (EGR-1) and late (TNF-α) genes occurred by sequential
recruitment of HATs and transcriptions factors in the course of
acute pancreatitis [66]. Importantly, the recovery of PP2A activity
by pentoxifylline was also associated with lowered IL-6 and ICAM-
1 expression [216].
Therefore, phosphorylation and chromatin remodeling by HATs
may be key processes in the regulation of pro-inﬂammatory genes
in acute pancreatitis. HATs recruitment and HDACs inactivation are
complex mechanisms that play a key role in the regulation of in-
ﬂammatory genes through phosphorylation and oxidative pro-
cesses, being HDACs more sensitive to cellular redox status [200].
Antioxidant supplementation
The beneﬁcial effects found with antioxidants, such as allo-
purinol, glutathione monoethyl ester, or N-acetyl cysteine[128,172–176], in rodents using different models of acute pan-
creatitis encouraged clinical trials to study the beneﬁts of anti-
oxidants in the disease. Unfortunately, although a large body of
experimental evidence has shown that free radicals play a key role
in the pathogenesis of acute pancreatitis, the clinical beneﬁt of
antioxidants remains far to be clear [164,165].
Often the beneﬁcial effect in experimental models was ob-
served when antioxidants were administered before the induction
of acute pancreatitis, and hence it may explain its lack of effec-
tiveness once the disorder is well established as it occurs in the
clinical management.
Some studies were designed to evaluate the potential beneﬁt of
different antioxidants in preventing acute pancreatitis after ERCP,
since it is well known that pancreatitis is the most common
complication after this clinical procedure. Although some studies
showed partial beneﬁcial effects of allopurinol [217] or beta car-
otene [218], NAC failed in preventing post-ERCP pancreatitis
[219,220]. Furthermore, a meta-analysis including eleven different
studies from 1999 to 2011 stated that antioxidant supplementation
with selenium, allopurinol, beta carotene, NAC, and pentoxifylline
is not justiﬁed in the treatment of post-ERCP pancreatitis [221].
Regarding the clinical beneﬁts of antioxidants in spontaneous
acute pancreatitis, the results are even more confusing and yielded
mixed results [12]. Different antioxidants, alone or in combination,
have been tested in the disease following treatments admini-
strated once acute pancreatitis was established. Initially, studies
performed in Germany showed beneﬁts such as reduced mortality
and decreased complications using selenium in acute pancreatitis
[222,223]. In agreement with these ﬁndings, 20 patients with re-
current attacks and/or constant pancreatic pain were treated with
an antioxidant cocktail containing selenium, vitamin C, beta car-
otene, vitamin E, and methionine, and these antioxidants were
able to reduce the number of attacks in the treated group vs.
placebo [224]. Moreover, treatment with high dose of vitamin C
resulted in lower complications and shorter in-ward days com-
pared with control group [225]. In contrast, other studies showed
statistically non-signiﬁcant reduction of hospital stay and a similar
complication rate between a group receiving vitamin C, NAC and
antoxyl forte, or placebo [226]. Finally, other trials observed no
effect using the different anti-oxidant combinations of selenium,
NAC and ascorbic acid [227–229].Conclusions and future research directions
In conclusion, different molecular mechanisms are involved in
local and systemic effects of AP triggering inﬂammatory gene ex-
pression and stimulating the production of pro-inﬂammatory cy-
tokines. Fig. 2 shows brieﬂy some of these mechanisms and their
relationship with oxidative stress. The latter is emerging as a
crucial modulator of cell signaling and a key promoter of the in-
ﬂammatory cascade, but its role is more complex than expected
and it is still beginning to be elucidated. Despite recent advance-
ments in the understanding of the pathophysiology of the disease,
the interaction of antioxidants and redox status with gene ex-
pression is far to be completely clariﬁed. More studies should be
conducted in order to elucidate the complex interactions between
oxidative stress and the early events in AP, in particular focused on
the role of oxidative stress and redox status in the epigenetic
modulation of pro-inﬂammatory genes in acute pancreatitis.
So far, clinical trials testing antioxidants in acute pancreatitis
have been insufﬁcient and conﬂicting, in some cases showing
limited effectiveness. It seems that targeting only oxidative stress
is not be powerful enough to stop the fast progression of acute
pancreatitis, a disease that starts up quickly and simultaneously
different pathogenic mechanisms. Therefore, future studies should
Fig. 2. Illustration showing the main mechanisms triggering acute pancreatitis.
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strategies based on antioxidants or redox modulators together
with direct anti-inﬂammatory therapies. In this regard, we tested
some years ago a co-treatment with oxypurinol – as water-soluble
xanthine oxidase inhibitor, and pentoxifylline – as inhibitor of
TNF-alpha production – administered intravenously in rats with
AP, which was able to abrogate the activation of ERK, JNK, and
p38α simultaneously in the pancreas leading to a marked reduc-
tion in the local and systemic inﬂammatory response [122]. Per-
haps, this co-treatment could serve as a basis for a future efﬁcient
combined therapy.Acknowledgments
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